Markets: 2026-10-08 Close

A sourced recap of the previous completed U.S. trading session. Closing moves are not real-time quotes.

What moved

- **S&P 500 (SPX)**: -0.47%, closed at 7,765.36 - **Nasdaq Composite (COMP)**: -1.25%, closed at 27,193.34 - **Dow Jones Industrial Average (DJIA)**: +0.10%, closed at 51,231.64 - **Russell 2000 (RUT)**: +0.03%, closed at 2,794.13

Sector leaders and laggards

- Leaders: Energy +2.92%; Consumer Staples +2.12%; Financials +0.91% - Laggards: Information Technology -1.78%; Consumer Discretionary -0.47%; Health Care -0.41%

Evidence behind the moves

Pacira BioSciences, Inc. (PCRX) +44.40%

Viatris announced an agreement to acquire Pacira for $36.50 per share in cash. A definitive cash offer produced the largest move in this selection; the stock closed $0.11 below the offer price.

Sources: dated closing quote, volume and market cap · primary transaction announcement

argenx SE (ARGX) -11.83%

argenx said it would discontinue its Phase 3 UNITY study in Sjögren’s disease after an independent committee recommended stopping it for futility. The setback removed a late-stage development opportunity at a large commercial biotechnology company.

Sources: dated closing quote, volume and market cap · primary clinical-study announcement

Haemonetics Corporation (HAE) +17.46%

Haemonetics disclosed that CSL expects to roll out its plasma-collection devices and disposables to all current U.S. CSL plasma centers by the end of 2027. The expanded expected deployment gives a material customer agreement a much broader potential scope.

Sources: dated closing quote, volume and market cap · primary customer-rollout disclosure

Chipotle Mexican Grill, Inc. (CMG) +6.21%

Shares rose after a Financial Times report that Starbucks had explored a potential Chipotle takeover. No agreed transaction was announced. An unconfirmed takeover report moved a major restaurant chain on exceptionally heavy trading.

Sources: dated closing quote and volume · corroborating reporting; proposal unconfirmed

Oracle Corporation (ORCL) -5.48%

Oracle fell amid the AI-stock selloff. Reporting also focused on gas-pipeline delays affecting its Project Jupiter data-center plans; the relative contribution of those concerns to the closing move is unverified. The decline involved a major AI-computing provider and more than $5.75 billion in estimated session dollar volume.

Sources: dated closing quote, volume and market cap · contemporaneous Project Jupiter reporting · corroborating background on pipeline setback

PepsiCo, Inc. (PEP) +3.73%

PepsiCo reported third-quarter results and updated its 2026 outlook; its shares gained despite a reduced profit-growth forecast. The positive closing reaction to mixed earnings and guidance made the consumer-staples bellwether notable.

Sources: dated closing quote, volume and market cap · primary earnings release

Accenture plc (ACN) +5.96%

Accenture and Dell announced an expanded collaboration, including an Accenture Dell Business Group focused on private AI and infrastructure modernization. The large consulting-company gain stood out on a day when the broader technology sector declined.

Sources: dated closing quote, volume and market cap · primary collaboration announcement

Applied Optoelectronics, Inc. (AAOI) -13.58%

Optical and AI-infrastructure suppliers sold off as investors reacted to reporting that OpenAI’s annualized revenue was about $20 billion below an earlier reported figure. No company-specific trigger was established. A double-digit decline on heavy volume made it a conspicuous example of the optical-supplier selloff.

Sources: dated closing quote, volume and market cap · corroboration of broader market news, not a company-specific cause · contemporaneous optical-supplier context

What remains uncertain

The cited announcements establish events and reported explanations, not the fraction of each price move caused by them. Unconfirmed catalysts remain hypotheses. Closing figures describe this session only.

What to watch next

Check subsequent company filings and results against the claims above, and whether the next sessions sustain or reverse these moves. A follow-up headline alone does not confirm the original explanation.

Stock spotlight

Today’s detailed follow-up focuses on **Pacira BioSciences, Inc. (PCRX)**, the strongest verified editorial candidate from this slate.

_MacroShed Markets is informational analysis, not investment advice._